Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Gastroenterology Physician in Long Beach, CA
NPI: 1174630586Primary Practice Location
VA LONG BEACH HEALTHCARE SYSTEM
5901 E 7th St, Long Beach, CA
Primary Employer
VA Long Beach Healthcare System
va.gov
HQ Phone
Get M.D. Timothy's Phone NumberMobile
Get M.D. Timothy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1979 - 2027
AZ State Medical License
1985 - 1987
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Gastroenterology
LAC-USC Medical Center
Fellowship • Hepatology
1982 - 1983
Fellowship • Hepatology
1985 - 1986
University of Arizona College of Medicine-Tucson
Fellowship • Gastroenterology
1983 - 1985
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
1978 - 1982
Emory School of Medicine
med.emory.edu
Medical School
Until 1978
Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
Authors: Ke-Qin Hu
Publication Date: 2005-08
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Authors: William Lee
Journal: N Engl J Med
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
Authors: Herbert Bonkovsky, Howard Strickler, Brian Edlin
Publication Date: 2014-12-02
Lead Sponsor: Timothy Morgan, MD
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Intervention / Treatment: DRUG: Standard of care, DRUG: Standard of care + pegfiltrastim
Lead Sponsor: University of Florida
Collaborators: AbbVie, Merck Sharp & Dohme LLC, Patient-Centered Outcomes Research Institute
Intervention / Treatment: DRUG: Ribavirin, DRUG: SOF/LDV (sofosbuvir/ledipasvir), DRUG: PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only), DRUG: EBR/GZR (elbasvir/grazoprevir)
Lead Sponsor: Southern California Institute for Research and Education
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA), University of Southern California, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, VA Long Beach Healthcare System
Intervention / Treatment: DRUG: Rilonacept, DRUG: Mycophenolate mofetil, DRUG: Prednisolone
